Clinical Trial Update: Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden

View source ↗

Summary

This completed trial update compares adherence to apixaban and warfarin among atrial fibrillation patients in Sweden, highlighting real-world usage patterns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Anticoagulation | Status: COMPLETED